A1 Refereed original research article in a scientific journal

Beta-interferon protects multiple sclerosis patients against enhanced susceptibility to infections caused by poor air quality




AuthorsOikonen MK, Eralinna JP

PublisherKARGER

Publication year2008

Journal: Neuroepidemiology

Journal name in sourceNEUROEPIDEMIOLOGY

Journal acronymNEUROEPIDEMIOLOGY

Volume30

Issue1

First page 13

Last page19

Number of pages7

ISSN0251-5350

DOIhttps://doi.org/10.1159/000113301


Abstract
Background: The monthly multiple sclerosis relapse rate was studied from January 1995 to March 2001 from hospital records in Southwestern Finland as a retrospective open-label study. Methods: The relapse rates of beta-interferon users and nonusers were compared to ambient air inhalable particle levels and viral infections in the population with logistic regression. Results: In the non-user group, relapses were more frequent 1 month following the episodes when PM 10 was in the highest quartile [logistic regression odds ratio = 1.196 (95% CI = 1.019-1.404), p = 0.028] and following adenovirus epidemics in the general population [ logistic regression odds ratio = 2.234 (95% CI = 1.013-4.926), p = 0.046]. PM10 and virus infections had no significant effects in interferon users. Conclusion: In addition to being antiviral, interferon also protected multiple sclerosis patients against an enhanced susceptibility to infections caused by PM10. Copyright (c) 2008 S. Karger AG, Basel.



Last updated on 26/11/2024 11:51:15 AM